Maple Biosys Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 29-06-2024
- Paid Up Capital ₹ 5.55 M
as on 29-06-2024
- Company Age 29 Year, 9 Days
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 5.25 Cr
as on 29-06-2024
- Satisfied Charges ₹ 1.22 Cr
as on 29-06-2024
- Revenue -98.50%
(FY 2016)
- Profit 16.40%
(FY 2016)
- Ebitda 14.97%
(FY 2016)
- Net Worth -659.90%
(FY 2016)
- Total Assets -16.48%
(FY 2016)
About Maple Biosys
The Corporate was formerly known as Maple Organics Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 5.55 M.
The company currently has active open charges totaling ₹5.25 Cr. The company has closed loans amounting to ₹1.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Kumar, Gurpreet Mangat, Surinder Kooner, and One other member serve as directors at the Company.
- CIN/LLPIN
U24219PB1995PLC017454
- Company No.
017454
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Dec 1995
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maple Biosys?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kumar  | Director | 03-Dec-2010 | Current |
| Gurpreet Mangat | Director | 08-Jul-2010 | Current |
| Surinder Kooner | Additional Director | 23-Jun-2016 | Current |
| Ramparkash Dhaliwal | Director | 11-Jan-2011 | Current |
Financial Performance of Maple Biosys.
Maple Biosys Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 98.5% decrease. The company also saw a substantial improvement in profitability, with a 16.4% increase in profit. The company's net worth observed a substantial decline by a decrease of 659.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maple Biosys?
In 2016, Maple Biosys had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 25 Feb 2011 | ₹2.50 M | Open |
Punjab National Bank Creation Date: 25 Feb 2011 | ₹4.00 Cr | Open |
Punjab National Bank Creation Date: 25 Feb 2011 | ₹1.00 Cr | Open |
How Many Employees Work at Maple Biosys?
Unlock and access historical data on people associated with Maple Biosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maple Biosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Biosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
